Primary Record
Sophoraflavanone G
- In stock
- 6,373 g
- Purity
- 98.1 %
- CAS
- 97938-30-2
Compound Identifiers & Properties
- CAS
- 97938-30-2
- PubChem CID
- 72936
- SMILES
- CC(=CC[C@H](CC1=C2C(=C(C=C1O)O)C(=O)C[C@H](O2)C3=C(C=C(C=C3)O)O)C(=C)C)C
- Canonical SMILES
- C=C(C)[C@H](CC=C(C)C)Cc1c(O)cc(O)c2c1O[C@H](c1ccc(O)cc1O)CC2=O
Names & Synonyms
- Sophoraflavanone G
- Vexibinol
- norkurarinone
- Kushenol F
- Kushnol F
- 97938-30-2
- SophoraflavanoneG
- (-)-Vexibinol
- NOR-KURARINONE
- AC1L2IZW
- AC1Q6KIL
- RefChem:184354
- (2S)-sophoraflavanone G
- GlyTouCan:G60464MQ
- D0VE0Q
- CHEMBL243148
- CHEBI:50209
- Sophoraflavanone G (Standard)
- DTXSID10243345
- orb1301311
- SCHEMBL2228023
- SCHEMBL29776828
- CTK5H9601
- HY-N1231R
- DTXCID10165836
- KST-1A0157
- C25H28O6
- CID72936
- G60464MQ
- HY-N1231
- ZINC2008850
- AR-1A3147
- BDBM50208611
- MFCD21333217
- MSK165715
- NP1972
- AKOS032948438
- ACN-046988
- C25-H28-O6
- EBC-515548
- FN74220
- AC-34326
- DA-58002
- LS-39548
- MS-27464
- SY120758
- 5,7,2',4'-tetrahydroxy-8-lavandulyl-flavanone
- J343.459A
- CS-0016619
- FT-0686651
- FT-0775939
- (2S)-2-(2,4-dihydroxyphenyl)-5,7-dihydroxy-8-[(2R)-5-methyl-2-(prop-1-en-2-yl)hex-4-en-1-yl]-2,3-dihydro-4H-chromen-4-one
- 2',4',5,7-Tetrahydroxy-6-lavandulylflavanone
- (2S)-5,7,2',4'-tetrahydroxy-8-lavandulylflavanone
- AH-214/21165021
- A1205947
- Q7563137
- (2S)-2-(2,4-dihydroxyphenyl)-5,7-dihydroxy-8-[(2R)-5-methyl-2-prop-1-en-2-ylhex-4-enyl]-2,3-dihydrochromen-4-one
- (S)-2-(2,4-Dihydroxyphenyl)-5,7-dihydroxy-8-((R)-5-methyl-2-(prop-1-en-2-yl)hex-4-en-1-yl)chroman-4-one
- 4H-1-Benzopyran-4-one, 2,3-dihydro-5,7-dihydroxy-2-(2,4-dihydroxyphenyl)-8-(5-methyl-2-(1-methylethenyl)-4-hexenyl)-, (S-(R*,S*))-
- (2S)-2-(2,4-dihydroxyphenyl)-5,7-dihydroxy-8-[(2R)-5-methyl-2-(prop-1-en-2-yl)hex-4-en-1-yl]-3,4-dihydro-2H-1-benzopyran-4-one
- 34981-24-3
- 5447-09-6
- (2S)-2-(2,4-Dihydroxyphenyl)-2,3-dihydro-5,7-dihydroxy-8-[(2R)-5-methyl-2-(1-methylethenyl)-4-hexenyl]-4H-1-Benzopyran-4-one; [S-(R*,S*)]-2-(2,4-Dihydroxyphenyl)-2,3-dihydro-5,7-dihydroxy-8-[5-methyl-2-(1-methylethenyl)-4-hexenyl]-4H-1-Benzopyran-4-one; (-)-Vexibinol; Kushenol F; Kushnol F; Norkurarinone; Vexibinol;
- (2S)-2-(2,4-dihydroxyphenyl)-5,7-dihydroxy-8-((2R)-5-methyl-2-(prop-1-en-2-yl)hex-4-en-1-yl)-2,3-dihydro-4H-chromen-4-one
- (2S)-2-(2,4-dihydroxyphenyl)-5,7-dihydroxy-8-((2R)-5-methyl-2-prop-1-en-2-ylhex-4-enyl)-2,3-dihydrochromen-4-one
- (2S)-2-(2,4-dihydroxyphenyl)-5,7-dihydroxy-8-[(2R)-2-isopropenyl-5-methyl-hex-4-enyl]chroman-4-one
- (2S)-2-(2,4-Dihydroxyphenyl)-5,7-dihydroxy-8-[(2R)-5-methyl-2-(prop-1-en-2-yl)hex-4-en-1-yl]-2,3-dihydro-4H-1-benzopyran-4-one
- (2S)-5,7-Dihydroxy-2,3-dihydro-2-(2,4-dihydroxyphenyl)-8-[(R)-5-methyl-2-(1-methylethenyl)-4-hexenyl]-4H-1-benzopyran-4-one
- (2S)-5,7-Dihydroxy-2,3-dihydro-2alpha-(2,4-dihydroxyphenyl)-8-[(R)-5-methyl-2-(1-methylethenyl)-4-hexenyl]-4H-1-benzopyran-4-one
- (2S)-5,7-Dihydroxy-2-(2,4-dihydroxyphenyl)-8-[(2R)-2-isopropenyl-5-methyl-4-hexenyl]-2,3-dihydro-4H-1-benzopyran-4-one
- (2S)-5,7-Dihydroxy-2alpha-(2,4-dihydroxyphenyl)-8-[(2R)-2-isopropenyl-5-methyl-4-hexenyl]-2,3-dihydro-4H-1-benzopyran-4-one
- (S)-2,3-Dihydro-5,7-dihydroxy-2-(2,4-dihydroxyphenyl)-6-[(R)-5-methyl-2-(1-methylethenyl)-4-hexenyl]-4H-1-benzopyran-4-one
- (S)-2-(2,4-Dihydroxyphenyl)-5,7-dihydroxy-8-[(R)-5-methyl-2-(prop-1-en-2-yl)hex-4-en-1-yl]chroman-4-one
- 2-(2,4-Dihydroxyphenyl)-5,7-dihydroxy-8-(2-isopropenyl-5-methyl-4-hexen-1-yl)-2,3-dihydro-4H-chromen-4-one
- 34981-26-5
- 4H-1-Benzopyran-4-one,2-(2,4-dihydroxyphenyl)-2,3-dihydro-5,7-dihydroxy-8-[(2R)-5-methyl-2-(1-methylethenyl)-4-hexen-1-yl]-,(2S)-